Atlas Trials

Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects

Clinical trial NCT01670734 · COMPLETED

Trial details

NCT number
NCT01670734
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypercholesterolemia
Start date
2012-09-01
Primary completion
2013-05-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.